🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment

Cells(2023)10.3390/cells12131783Source: DataRank Database

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment is a research paper published in Cells (2023). On theSindex it has a DataRank of 0.530. It has been cited 17 times, with 17 citing works in its 1-hop citation network.

N/A
0.530DataRank · unranked

Scored on demand from live citation data

17 citations · 17 citing works in its network
Download PDF
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Impact (FWCI 3.33)OA: goldTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (0/2)
    Interoperable (0/2)
      Reusable (0/3)

        FAIR checklist signals are shown for context only and do not affect DataRank scoring.

        Run a calibrated FAIR evaluation for this paper →

        We only score data papers we can read in full — never from an abstract alone.

        DataRank Breakdown

        Base Score 82%Citation Network 18%

        Base Score Contribution

        0.434

        From this paper's citation signal

        Citation Network Contribution

        0.0964

        From 7 citing papers with measurable signal

        Learn more about DataRank methodology →

        Top 5 citers driving the network score

        Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.

        1. Challenges of CD30 expression and its impact on targeted treatment responses in non-Hodgkin lymphoma: New perspectives for evaluation and validation
          Pathology - Research and Practice20255 citations68 referencesContributes 0.026
        2. Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations
          Clinical Medicine Insights Oncology202452 citations152 referencesContributes 0.026
        3. Hodgkin Lymphoma Classification—From Historical Concepts to Current Refinements
          Cancers20257 citations94 referencesContributes 0.022
        4. Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies
          Andrology20246 citations118 referencesContributes 0.016
        5. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review
          Frontiers in Immunology202410 citations260 referencesContributes 0.009

        Authors (7)

        Dana Antonia ȚăpoiORCID,Georgian Halcu,Octavian Munteanu,David-Ioan DumitrascuORCID,Mihail Constantin CeaușuORCID
        Live enrichment
        PubMed:37443818OpenAlex:https://openalex.org/W4383369002

        FWCI

        3.33

        Citation Percentile

        0.9%

        Citation Trend

        2023
        2024
        2025
        2026

        goldLicense: cc-by
        journalhttps://www.mdpi.com/2073-4409/12/13/1783/pdf?version=1688538781
        publisherhttps://www.mdpi.com/2073-4409/12/13/1783/pdf?version=1688538781
        publisherhttps://www.mdpi.com/2073-4409/12/13/1783/pdf
        journalhttps://doi.org/10.3390/cells12131783
        repositoryhttps://pubmed.ncbi.nlm.nih.gov/37443818

        Fields of Study

        Lymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchCNS Lymphoma Diagnosis and TreatmentHumansHodgkin DiseaseLymphomaLymphoma, Large-Cell, AnaplasticReed-Sternberg CellsKi-1 AntigenBiomarkers, Tumor

        MeSH Terms

        Hodgkin DiseaseHumansLymphomaBiomarkers, TumorReed-Sternberg CellsLymphoma, Large-Cell, AnaplasticKi-1 Antigen

        Keywords

        CD30LymphomaAnaplastic large-cell lymphomaCancer researchCancerImmune systemTumor necrosis factor alphaImmunologyBiologyMedicinePathologyInternal medicineHodgkin lymphomaanaplastic large cell lymphomacancer treatmentembryonal carcinomatumor marker

        Sustainable Development Goals

        SDG 0: Good health and well-being